Penny Stocks That Pack a Punch: 3 Names to Ride for 10X Gains
- One of the many advantages of penny stocks is that you can easily create a customized portfolio. diversified across various sectors, geographies, and business types, allowing for the creation of a tailored portfolio that aligns closely with individual investment goals.
- 06/04/2024
|
Why Is Akanda (AKAN) Stock Up 133% Today?
- Akanda (NASDAQ: AKAN ) stock is rocketing higher on Friday alongside heavy pre-market trading of the cannabis company's shares. This has more than 6.3 million shares of AKAN stock changing hands as of this writing.
- 05/24/2024
|
Akanda Announces Stock Consolidation
- London, United Kingdom--(Newsfile Corp. - May 21, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, reported that it expects to implement a 1-for-40 reverse stock split on its ordinary shares effective May 23, 2024, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the ordinary shares will continue on The Nasdaq Capital Market under the symbol "AKAN".
- 05/21/2024
|
Akanda Announces Closing of Subsequent Registered Direct Offering
- London, United Kingdom--(Newsfile Corp. - May 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced second registered direct offering for the sale and issuance of 2,491,381common shares at a purchase price of $0.1031 and 12,057,600 pre-funded warrants to purchase 12,057,600 common shares at $0.103 per share, priced at the Minimum Price under the Nasdaq rules. The pre-funded warrants are immediately exercisable for $0.0001 per share and may be exercised at any time until all of the pre-funded warrants are exercised in full, subject to certain beneficial ownership limitations as set forth in the pre-funded warrant.
- 05/20/2024
|
Akanda Corp. Announces Subsequent Registered Direct Offering
- London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a second securities purchase agreement with an accredited investor whereby the investor has agreed to purchase 2,491,381common shares at a purchase price of $0.1031 and 12,057,600 pre-funded warrants to purchase 12,057,600 common shares at $0.103 per share in a registered direct offering priced at Minimum Price under Nasdaq rules. The pre-funded warrants are immediately exercisable at an exercise price of $0.0001 and may be exercised at any time until all of the pre-funded warrants are exercised in full, subject to certain beneficial ownership limitations as set forth in the pre-funded warrant.
- 05/17/2024
|
Akanda Announces Closing of Registered Direct Offering
- London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 2,491,381 common shares at a purchase price of $0.1031 per share, and 21,756,922 pre-funded warrants to purchase 21,756,922 common shares at a price of $0.103 per share, priced at the Minimum Price under the Nasdaq rules. The pre-funded warrants are immediately exercisable for $0.0001 per share and may be exercised at any time until all of the pre-funded warrants are exercised in full, subject to certain beneficial ownership limitations as set forth in the pre-funded warrant.
- 05/17/2024
|
Akanda Corp. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- London, United Kingdom--(Newsfile Corp. - May 17, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a securities purchase agreement with an accredited investor whereby the investor has agreed to purchase 2,491,381 common shares at a purchase price of $0.1031 and 21,756,922 pre-funded warrants to purchase 21,756,922 common shares at $0.103 per share in a registered direct offering priced at Minimum Price under Nasdaq rules. The pre-funded warrants are immediately exercisable at an exercise price of $0.0001 and may be exercised at any time until all of the pre-funded warrants are exercised in full, subject to certain beneficial ownership limitations as set forth in the pre-funded warrant.
- 05/17/2024
|
Akanda Corp receives non-compliance notice from Nasdaq
- Akanda Corp (NASDAQ: AKAN) is in focus this morning after receiving a notice of non-compliance from Nasdaq. Akanda fails to satisfy the Nasdaq listing requirements The deficiency notification was issued to the international medical cannabis company because it failed to meet the “minimum stockholders' equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1).
- 05/17/2024
|
Why Is Akanda (AKAN) Stock Up 164% Today?
- Akanda (NASDAQ: AKAN ) stock is heading higher on Friday despite the cannabis company getting a non-compliance notice from the Nasdaq Exchange. The issue here is AKAN stock not meeting the minimum stockholders' equity requirement to remain on the Nasdaq Exchange.
- 05/17/2024
|
Akanda Corp. Receives Notice of Non-Compliance from NASDAQ
- London, United Kingdom--(Newsfile Corp. - May 16, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), announced that it has received a deficiency notification letter from the Nasdaq Listing Qualifications Department on May 14, 2024, due to non-compliance with the minimum stockholders' equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1). According to Nasdaq's listing requirements, companies must maintain a minimum stockholders' equity of $2,500,000.
- 05/16/2024
|
Akanda Corp Announces Settlement Agreement with Former CEO Tejinder Virk
- London, United Kingdom--(Newsfile Corp. - May 13, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), today announced a settlement agreement with former chief executive officer and director, Tejinder Virk, concluding a series of disputes that commenced following Mr. Virk's resignation on February 3, 2023.
- 05/13/2024
|
Akanda Corp. Announces Plans to Be Among International First Movers Pending Completion of Landmark Change in US Drug Policy
- London, United Kingdom--(Newsfile Corp. - May 10, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces it is actively following the landmark change in federal US policy to reschedule cannabis under the Controlled Substances Act ("CSA"). It has been widely reported that as of April 30, 2024 the DEA plans to reclassify cannabis as a Schedule III substance.
- 05/10/2024
|
Akanda Appoints Cooper to the Board of Directors
- London, United Kingdom--(Newsfile Corp. - April 25, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, Akanda Corp. announces the appointment of Christopher Cooper to its board of directors following the resignation of Harvinder Singh as a director. Mr. Christopher Cooper has over 20 years of extensive business experience in all facets of corporate development, senior management, finance and operations, in both the private and public sectors.
- 04/25/2024
|
Akanda Announces No Equity Financing Until Further Notice
- London, United Kingdom--(Newsfile Corp. - April 15, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, previously announced the completion of several public offerings and the sale of its indirectly wholly-owned Portuguese subsidiary, RPK BioPharma Unipessoal, LDA ("RPK") now announces its plans to pause any potential equity financings for a thirty (30) day period while the Board meets and confers. The Company plans to evaluate and pursue strategic investments in international cannabis plant touching markets as well as ancillary technology services.
- 04/15/2024
|
Akanda Announces Plans to Enter Blockchain and AI Technology Sector
- London, United Kingdom--(Newsfile Corp. - April 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, announces its plans to enter the blockchain and artificial intelligence sector of the cannabis industry. With an increasingly complex and global supply chain for the international cannabis industry, the Company believes companies and consumers will turn to blockchain and smart contracts to verify the authenticity of genetics, plants, and products alike.
- 04/12/2024
|
AKAN Stock Pops as Akanda Eyes Entry into German Cannabis Market
- Akanda (NASDAQ: AKAN ) stock is getting a boost on Friday after the cannabis company revealed it's considering expanding into the German market. Akanda is looking into investing in the German cannabis market after the country legalized some recreational marijuana use.
- 04/12/2024
|
Akanda Looks to Commercialize and Capitalize on Germany's Legalization of Cannabis, Opening Path to $3BN Market
- London, United Kingdom--(Newsfile Corp. - April 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, Akanda Corp. announces its plans to evaluate and pursue strategic investments in the expanded legalized German market. On April 1, 2024, Germany became the third European Union country to legalize cannabis for personal use after Malta and Luxembourg.
- 04/12/2024
|
Akanda Corp. Announces Plan to Integrate Technology Solutions to Capture UK Market
- London, United Kingdom--(Newsfile Corp. - April 11, 2024) - On April 4, 2024, Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, announced its wholly-owned United Kingdom (UK) subsidiary, Canmart, plans to develop its social shopping capability by integrating with META, to create a user friendly buying experience for Facebook and Instagram users to purchase Canmart products. In short, this integration allows Facebook and Instagram users to browse products featured in Canmart shoppable videos, place products in a native shopping cart and checkout all without leaving Facebook or Instagram.
- 04/11/2024
|
Akanda Corp. Announces Closing of the Sale of RPK
- London, United Kingdom--(Newsfile Corp. - April 11, 2024) - On April 1, 2024, Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, completed the transaction with SOMAÍ Pharmaceuticals Ltd. (the "Buyer") for the sale of RPK, its indirect wholly-owned Portuguese subsidiary.
- 04/11/2024
|
Akanda Corp. Announces Canmart's Plans for Facebook and Instagram Social Shopping Technology Integration
- London, United Kingdom--(Newsfile Corp. - March 28, 2024) - Akanda Corp. ("Akanda" or the "Company") (NASDAQ: AKAN), an international medical cannabis company, Akanda Corp. announced its wholly-owned United Kingdom (UK) subsidiary, Canmart, plans to develop its social shopping capability by integrating with META, to create a user friendly buying experience for Facebook and Instagram users to purchase Canmart products. In short, this integration allows Facebook and Instagram users to browse products featured in Canmart shoppable videos, place products in a native shopping cart and checkout - all without leaving Facebook or Instagram.
- 03/28/2024
|
Akanda Corp. Announces Strategic Plan to Evaluate and Enter Bitcoin, Blockchain, AI Segments of the Cannabis Market
- London, United Kingdom--(Newsfile Corp. - March 28, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, announced aspirations to enter technology segments of the cannabis industry. The Company is evaluating potential opportunities to enter Bitcoin, Blockchain, and AI applications in the cannabis industry.
- 03/28/2024
|
Akanda Corp. Announces Closing of Underwritten Public Offering
- London, United Kingdom--(Newsfile Corp. - March 27, 2024) - On March 24, 2024, Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, entered into an underwriting agreement (the "Underwriting Agreement") with Univest Securities, LLC ("Univest") as the underwriter in connection with the issuance and sale by the Company in an underwritten public offering (the "Offering") of 3,087,443 of the Company's Common Shares, no par value per share (the "Common Shares" and, such number of Common Shares issued and sold in the Offering, the "Offered Shares"), at a purchase price of $0.1217 per Offered Share, and pre-funded warrants to purchase 37,997,190 Common Shares at a purchase price of each pre-funded warrant equal to the price at which one Common Share is sold in the Offering, minus $0.0001, and the exercise price of each pre-funded warrant is $0.0001 per share (the "Pre-Funded Warrants" and, such number of Pre-Funded Warrants issued and sold in the Offering, the "Offered Pre-Funded Warrants"), pursuant to the Company's effective registration statement on Form F-1 (File No. 333-277182) and a related preliminary prospectus, together with the related final prospectus dated as of March 26, 2024 (such registration statement, preliminary prospectus and the final prospectus, collectively, the "Registration Statement"), filed with the Securities and Exchange Commission.
- 03/27/2024
|
Akanda Corp. Announces Pricing of Underwritten Public Offering
- London, United Kingdom--(Newsfile Corp. - March 25, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has entered into a firm commitment underwriting agreement with Univest Securities, LLC, as underwriter, whereby Univest has agreed to purchase up to 41,084,634 common shares or pre-funded warrants at a public offering price of $0.1217 per share or $0.1216 per pre-funded warrant in an underwritten public offering. The gross proceeds to Akanda are estimated to be approximately $5,000,000 before deducting the underwriter fees and other offering expenses.
- 03/25/2024
|
RETRANSMISSION: Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals
- London, United Kingdom--(Newsfile Corp. - March 1, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced the signing of a definitive Share Purchase Agreement and Escrow Agreement with Somai Pharmaceuticals Unipessoal, LDA ("Somai"), marking a significant milestone in the sale of its Portuguese subsidiary, RPK BioPharma Unipessoal, LDA ("RPK"). This strategic move underscores both companies' commitment to advancing the medical cannabis industry and enhancing patient access to high-quality cannabis treatments.
- 03/01/2024
|
Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals
- London, United Kingdom--(Newsfile Corp. - February 29, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced the signing of a definitive Share Purchase Agreement and Escrow Agreement with Somai Pharmaceuticals Unipessoal, LDA ("Somai"), marking a significant milestone in the sale of its Portuguese subsidiary, RPK BioPharma Unipessoal, LDA ("RPK"). This strategic move underscores both companies' commitment to advancing the medical cannabis industry and enhancing patient access to high-quality cannabis treatments.
- 02/29/2024
|
Akanda Corp. Provides Further Update on Annual Meeting of its Shareholders
- London, United Kingdom--(Newsfile Corp. - February 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces that it has received an order from the Ontario Superior Court of Justice (the "Court") permitting Akanda to hold its annual meeting of shareholders (the "Meeting") on or before March 23, 2024, pursuant to an application to the Court previously announced by the Company on February 20, 2024. Prior to the order from the Court, the Company would have had to hold the Meeting on or before February 22, 2024.
- 02/20/2024
|
Akanda Corp. Provides Update on Annual Meeting of its Shareholders
- London, United Kingdom--(Newsfile Corp. - February 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces that it has made an application to the Ontario Superior Court of Justice (the "Court") to extend the deadline for it to hold its annual meeting of shareholders (the "Meeting") from February 22, 2024 to March 23, 2024. Under Ontario law, the Company must hold the Meeting within 15 months from the prior meeting, which would be February 22, 2024.
- 02/20/2024
|
Akanda Corp. Discusses Positive Trends in UK Cannabis Market
- London, United Kingdom--(Newsfile Corp. - February 13, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), provides an overview of the growing cannabis market in the United Kingdom and promising trends among patients. 2023 was a dynamic year for the UK cannabis market.
- 02/13/2024
|
Akanda Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- London, United Kingdom--(Newsfile Corp. - February 2, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 280,851 common shares at a purchase price of $0.406 per share, and pre-funded warrants to purchase 1,462,991 common shares at a price of $0.4059 per share, priced at-the-market under the Nasdaq rules. The pre-funded warrants are immediately exercisable for $0.0001 per share and may be exercised at any time until all of the pre-funded warrants are exercised in full, subject to certain beneficial ownership limitations as set forth in the pre-funded warrant.
- 02/02/2024
|
Akanda Corp. Provides Update on Scheduling Policy in US Aims to Be Among First International Movers in US Pending Approval
- London, United Kingdom--(Newsfile Corp. - February 2, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announces it is actively following the developments in federal US policy to reschedule and/or deschedule cannabis under the Controlled Substances Act ("CSA"). The Company believes rescheduling may reinvigorate capital markets and could lead to changes in NASDAQ and NYSE rules on listing plant-touching U.S. companies.
- 02/02/2024
|
The Penny Stock Trader's Guide to Technical Indicators
- Use these technical indicators when trading penny stocks The post The Penny Stock Trader's Guide to Technical Indicators appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 05/04/2023
|
Why Is Akanda (AKAN) Stock Up 114% Today?
- Akanda (NASDAQ: AKAN ) stock is on the rise Wednesday after the cannabis company released its annual report. Akanda originally filed a notice with the Securities and Exchange Commission (SEC) yesterday noting that it would be late in filing its annual report.
- 05/03/2023
|
Why Is Akanda (AKAN) Stock Up 31% Today?
- Akanda (NASDAQ: AKAN ) stock is on the rise Friday as the company's shares continue a rally that started yesterday. That rally was kicked off by an update from the U.S. Food and Drug Administration (FDA).
- 01/27/2023
|
Why Is Akanda (NASDAQ:AKAN) Stock Up 200% Today?
- Shares of cannabis specialist Akanda (NASDAQ: AKAN ) skyrocketed 200% this morning before significantly paring back gains. With AKAN stock still up more than 60% this afternoon, though, today's move remains impressive.
- 01/26/2023
|
Akanda pivots to German market as cannabis reform gains traction
- Akanda Corp. CEO Taj Virk is pivoting the micro-capitalization cannabis company toward the European Union amid rising interest in the sector as German Chancellor Olaf Scholz continues to push for marijuana legalization.
- 08/30/2022
|
Weed Stocks This Week: Major Earnings Blitz
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.
- 08/12/2022
|
Best Penny Stocks To Buy? 4 To Watch Right Now
- Best penny stocks to buy now? Check these out for your watch list this week.
- 08/09/2022
|
These 7 Cannabis Stocks Just Dropped Smoking Hot News
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.
- 07/15/2022
|
Are These Cannabis Stocks Heating Up or Just Blowing Smoke?
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.
- 07/01/2022
|
It's 420 Holiday Week! These 9 Cannabis Stocks Are on Fire
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.
- 04/22/2022
|
Akanda buys Portugal unit of Canada's Flowr
- Cannabis company Akanda Corp. AKAN, -4.19% said Wednesday it agreed to acquire Portugal-based Holigen from Canada's The Flowr Corp. FLWR, FLWPF, -3.33% for about $28 million, including the assumption of $4.3 million in debt. The deal includes $3 million in cash, 1.9 million Akanda common shares valued $19.6 million based on the stock's closing price of $10.30 a share; also the assumption of about $4.3 million of debt.
- 04/20/2022
|
Why Akanda Stock Blasted Nearly 14% Higher Today
- The company's top shareholder opens its first dispensary in Los Angeles.
- 03/21/2022
|
U.S. IPO Weekly Recap: Cannabis Micro-Cap Breaks The IPO Market's Dry Spell
- A cannabis micro-cap broke the IPO market's month-long dry spell this past week and became the latest small issuer to soar in its debut, popping 163% on its first day.
- 03/19/2022
|
10 Smoking Hot Cannabis Stocks to Keep on Your Radar
- Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.
- 03/18/2022
|
Cannabis company Akanda's stock rockets in trading debut
- Akanda Corp. shares rocketed in their trading debut on the Nasdaq on Tuesday less than a year after the cannabis company was formed.
- 03/15/2022
|
Akanda Set to Trade its Shares on Tuesday
- The medical cannabis company sold 4 million shares at its expected price of $4.
- 03/14/2022
|
